Hospital Raja Perempuan Zainab II

Kelantan 15586

1 studies enrolling now · 5 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, Bronchiectasis, Cardiovascular Diseases, Chronic Heart Failure With Preserved Ejection Fraction, Diabetes Mellitus, Type 2, High-risk Transient Ischemic Attack, Hypertension, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed